Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardiff LexingtonCDIX +0.79%27 Days Payable is 117.90 as of Mar. 2026, which is 94% above its 10-year median of 60.62. GuruFocus rates CDIX with a GF Score™ of 27/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Cardiff Lexington ranks better than 64.74% on this metric.
The historical rank and industry rank for Cardiff Lexington's Days Payable or its related term are showing as below:
CDIX'
s Days Payable Range Over the Past 10 Years
Min: 14.09 Med: 60.62 Max: 162.65
Current: 81.01
During the past 13 years, Cardiff Lexington's highest Days Payable was 162.65. The lowest was 14.09. And the median was 60.62.
CDIX's Days Payable is ranked better than 64.74% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs CDIX: 81.01
Cardiff Lexington's Days Payable
increased
from Mar. 2025 (59.16) to Mar. 2026 (117.90).
It may suggest that Cardiff Lexingtondelayed paying its suppliers.
The historical data trend for Cardiff Lexington's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cardiff Lexington's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardiff Lexington Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cardiff Lexington's Days Payable distribution charts can be found below:
* The bar in red indicates where Cardiff Lexington's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Cardiff Lexington's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardiff Lexington (CDIX) has a Days Payable of 117.90 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cardiff Lexington and its competitors. This is 94% above median its historical median of 60.62. Over the past decade, Cardiff Lexington's Days Payable has ranged from 14.09 to 162.65. According to the industry distribution chart, Cardiff Lexington ranks #214 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 35.3%.
Is Cardiff Lexington's Days Payable too high?
Cardiff Lexington's current Days Payable of 117.90 is 94% above median its 10-year median of 60.62. Over the past 10 years, this metric has ranged from a low of 14.09 to a high of 162.65. The Healthcare Providers & Services industry median Days Payable is 56.95. Cardiff Lexington's value of 117.90 is 107% above this industry median. Based on the distribution chart, Cardiff Lexington ranks #214 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Cardiff Lexington has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardiff Lexington's Days Payable compare to AMS and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Cardiff Lexington ranks #214 out of 607 companies for Days Payable. This puts Cardiff Lexington in the upper half of its industry. The industry median Days Payable is 56.95. Cardiff Lexington's value of 117.90 is 107% above this benchmark. Historically, Cardiff Lexington's own Days Payable has ranged from 14.09 to 162.65 over the past decade. While the company's 10-year median is 60.62 vs. the industry median of 56.95, Cardiff Lexington has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardiff Lexington's current Days Payable of 117.90 is 107% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cardiff Lexington and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiff Lexington's current Days Payable is 117.90, which is 94% above median its own 10-year median of 60.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiff Lexington stock overvalued right now?
Based on GuruFocus' analysis, Cardiff Lexington (CDIX) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.51 — trading 537.5% above its estimated fair value. The current Days Payable is 117.90, which is 94% above median its 10-year median of 60.62 and 107% above the Healthcare Providers & Services industry median of 56.95. Cardiff Lexington's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cardiff Lexington (CDIX), the current Days Payable is 117.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardiff Lexington (CDIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardiff Lexington stock appears to be overvalued.
The current stock price of $0.51 is trading 537.5% above its estimated GF Value™ of $0.08.
GuruFocus considers Cardiff Lexington to be Significantly Overvalued.
Key valuation signals for CDIX:
Days Payable: 117.90 (94% above median its 10-year median of 60.62)
GF Value™: $0.08 vs. price of $0.51 (537.5% above fair value)
Industry Position: 107% above the Healthcare Providers & Services median (#214 of 607)
No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
27GF Score
Get the complete analysis for CDIX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDIX has been successfully added to your 
